Polar Asset Management Partners Inc. grew its stake in Envista Holdings Co. (NYSE:NVST - Free Report) by 27.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,914,799 shares of the company's stock after purchasing an additional 417,549 shares during the quarter. Polar Asset Management Partners Inc. owned approximately 1.11% of Envista worth $36,936,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the stock. Treasurer of the State of North Carolina raised its holdings in Envista by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock valued at $1,458,000 after acquiring an additional 480 shares during the period. Amalgamated Bank grew its position in shares of Envista by 0.7% in the fourth quarter. Amalgamated Bank now owns 80,380 shares of the company's stock valued at $1,551,000 after purchasing an additional 523 shares during the last quarter. M&T Bank Corp increased its stake in shares of Envista by 4.2% during the fourth quarter. M&T Bank Corp now owns 16,621 shares of the company's stock worth $320,000 after purchasing an additional 676 shares during the period. Assetmark Inc. increased its stake in shares of Envista by 2.5% during the fourth quarter. Assetmark Inc. now owns 39,624 shares of the company's stock worth $764,000 after purchasing an additional 983 shares during the period. Finally, Xponance Inc. lifted its holdings in Envista by 5.8% during the 4th quarter. Xponance Inc. now owns 19,726 shares of the company's stock worth $381,000 after purchasing an additional 1,077 shares during the last quarter.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently weighed in on the company. Piper Sandler dropped their target price on Envista from $18.00 to $17.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. UBS Group dropped their price objective on shares of Envista from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Monday, May 5th. Morgan Stanley set a $16.00 target price on shares of Envista in a research report on Tuesday, April 15th. Wells Fargo & Company set a $19.00 price target on shares of Envista in a research report on Saturday, March 8th. Finally, New Street Research set a $19.00 price target on Envista in a research note on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Envista presently has a consensus rating of "Hold" and a consensus target price of $20.08.
Check Out Our Latest Research Report on NVST
Envista Trading Down 3.8%
Shares of NVST opened at $17.90 on Thursday. Envista Holdings Co. has a 52-week low of $14.22 and a 52-week high of $23.00. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. The business's fifty day moving average is $16.49 and its 200-day moving average is $18.98. The firm has a market cap of $3.03 billion, a price-to-earnings ratio of -2.76, a PEG ratio of 1.27 and a beta of 0.97.
Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. The company had revenue of $616.90 million for the quarter, compared to the consensus estimate of $608.17 million. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. The firm's quarterly revenue was down 1.1% compared to the same quarter last year. During the same period last year, the company posted $0.26 EPS. Equities analysts anticipate that Envista Holdings Co. will post 1 EPS for the current fiscal year.
Envista Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
